LAWRENCE, Mass., Jan. 25 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2007 on Tuesday, February 12, 2008 before the opening of the financial markets.
NxStage will also host a conference call at 9:00 a.m. Eastern Time on February 12, 2008 to discuss its fourth quarter and year end 2007 financial results. To listen to the conference call, please dial 888-713-4214 for domestic callers and 617-213-4866 for international callers. The passcode is 20821233. A replay of the conference call will be available 2 hours after the start of the call through February 26, 2008 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 30075901. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at http://www.nxstage.com.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at http://www.nxstage.com.
This release contains "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. All statements
contained in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended to
identify forward- looking statements. The forward-looking statements in
this release include NxStage's plan to release its financial results on
February 12, 2008. Actual results may differ materially from those
indicated by these forward-looking statements as a result of various
important factors including, but not limited to, unexpected difficulty in
closing the company's financial books for the quarter and other factors
that are discussed in NxStage's Quarterly Report on Form 10- Q for the
period ended September 30, 2007 filed with the SEC. NxStage is under no
obligation to (and expressly disclaims any such obligation to) update or
alter its forward-looking statements, whether as a result of new
information, future events or otherwise.
Stephanie Marks of NxStage Medical, Inc.,
Web site: http://www.nxstage.com
|SOURCE NxStage Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved